Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Metsera Inc., Common Stock

MTSR

NSQ

$30.58

+$0.55

(1.83%)

Sector: Healthcare

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$3.15B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

293.09K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$18 L

$32.05 H

$30.58

About Metsera Inc., Common Stock

Metsera Inc is a United States-based biopharmaceutical company. The Company is engaged in developing medicines and solutions for obesity and metabolic diseases. It offers a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with profiles to address multiple therapeutic targets and meet the future needs of a weight loss treatment landscape. Its solutions helps to reduce the physical, emotional, and economic burdens of obesity as a driver of diseases. In addition it offers HALO, which is a peptide lipidation platform technology, which enables peptides to bind simultaneously to albumin and to a drug target. more

Sector: Healthcare

Returns

Data is not properly formatted.

Time Frame	MTSR		S&P500
1-Week Return	3.66%%	%	1.53%%
1-Month Return	69.89%%	%	4.75%%

Financials

	Dec '23
Total Revenue	-	[{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	[{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	[{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	[{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	29.45M	[{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	(29.45M)	[{"date":"2023-12-31","value":-2944800000,"profit":false}]
Total Non-Operating Income/Expense	(16.60M)	[{"date":"2023-12-31","value":-1660000000,"profit":false}]
Pre-Tax Income	(46.05M)	[{"date":"2023-12-31","value":-4604800000,"profit":false}]
Income Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(46.05M)	[{"date":"2023-12-31","value":-4604800000,"profit":false}]
Income From Discontinued Operations	-	[{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(46.05M)	[{"date":"2023-12-31","value":-4604800000,"profit":false}]

EPS (Diluted)	-	[{"date":"2023-12-31","value":"-","profit":true}]

	Dec '23
Total Revenue	-	[{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	[{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	[{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	[{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	[{"date":"2023-12-31","value":"-","profit":true}]
Operating Income	-	[{"date":"2023-12-31","value":"-","profit":true}]
Total Non-Operating Income/Expense	-	[{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income From Discontinued Operations	-	[{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	[{"date":"2023-12-31","value":"-","profit":true}]

EPS (Diluted)	-	[{"date":"2023-12-31","value":"-","profit":true}]

	Dec '23
Total Revenue	-	[{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	[{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	[{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	[{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	10.06M	[{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	(10.06M)	[{"date":"2023-12-31","value":-1006200000,"profit":false}]
Total Non-Operating Income/Expense	(1.81M)	[{"date":"2023-12-31","value":-180900000,"profit":false}]
Pre-Tax Income	(11.87M)	[{"date":"2023-12-31","value":-1187100000,"profit":false}]
Income Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(11.87M)	[{"date":"2023-12-31","value":-1187100000,"profit":false}]
Income From Discontinued Operations	-	[{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(11.87M)	[{"date":"2023-12-31","value":-1187100000,"profit":false}]

EPS (Diluted)	-	[{"date":"2023-12-31","value":"-","profit":true}]

	Dec '23
Total Revenue	-	[{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	[{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	[{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	[{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	[{"date":"2023-12-31","value":"-","profit":true}]
Operating Income	-	[{"date":"2023-12-31","value":"-","profit":true}]
Total Non-Operating Income/Expense	-	[{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	[{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	[{"date":"2023-12-31","value":"-","profit":true}]
Income From Discontinued Operations	-	[{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	[{"date":"2023-12-31","value":"-","profit":true}]

EPS (Diluted)	-	[{"date":"2023-12-31","value":"-","profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	14.98M	76.80M	[{"date":"2022-12-31","value":19.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	92.04M	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	14.98M	168.84M	[{"date":"2022-12-31","value":8.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	613.00K	20.17M	[{"date":"2022-12-31","value":3.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	15.18M	193.85M	[{"date":"2022-12-31","value":7.83,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	15.79M	214.02M	[{"date":"2022-12-31","value":7.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	(813.00K)	(48.02M)	[{"date":"2022-12-31","value":-81300000,"profit":false},{"date":"2023-12-31","value":-4801900000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	(813.00K)	(45.18M)	[{"date":"2022-12-31","value":-81300000,"profit":false},{"date":"2023-12-31","value":-4518200000,"profit":false}]

Total Liabilities & Shareholders Equity	14.98M	168.84M	[{"date":"2022-12-31","value":8.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	-	412.71%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Assets	-	1027.11%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	3190.21%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	-	1177.04%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	1255.18%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	5806.40%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	5457.44%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	1027.11%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '23	Sep '24
Total Assets
Current Assets	76.80M	190.99M	[{"date":"2023-12-31","value":40.21,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Non-current Assets	92.04M	96.28M	[{"date":"2023-12-31","value":95.59,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Total Assets	168.84M	287.27M	[{"date":"2023-12-31","value":58.77,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	20.17M	71.93M	[{"date":"2023-12-31","value":28.04,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Non-current Liabilities	193.85M	412.05M	[{"date":"2023-12-31","value":47.05,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Total Liabilities	214.02M	483.98M	[{"date":"2023-12-31","value":44.22,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Retained Earnings	(48.02M)	(204.28M)	[{"date":"2023-12-31","value":-4801900000,"profit":false},{"date":"2024-09-30","value":-20427500000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Total Shareholders' equity	(45.18M)	(196.71M)	[{"date":"2023-12-31","value":-4518200000,"profit":false},{"date":"2024-09-30","value":-19670900000,"profit":false}]

Total Liabilities & Shareholders Equity	168.84M	287.27M	[{"date":"2023-12-31","value":58.77,"profit":true},{"date":"2024-09-30","value":100,"profit":true}]

	Dec '23	Sep '24
Total Assets
Current Assets	-	148.67%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Non-current Assets	-	4.61%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Total Assets	-	70.14%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	256.62%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Non-current Liabilities	-	112.56%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Total Liabilities	-	126.13%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Retained Earnings	-	325.40%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true}]
Total Shareholders' equity	-	335.37%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	70.14%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-09-30","value":100,"profit":true}]

	Dec '23
Operating Activities
Net Operating Cash Flow	(35.39M)	[{"date":"2023-12-31","value":-3539300000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	123.68M	[{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	60.22M	[{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(35.42M)	[{"date":"2023-12-31","value":-3542200000,"profit":false}]

	Dec '23
Operating Activities
Net Operating Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Net Change in Cash	-	[{"date":"2023-12-31","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

	Dec '23
Operating Activities
Net Operating Cash Flow	(13.31M)	[{"date":"2023-12-31","value":-1331200000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	22.37M	[{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	9.26M	[{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(13.31M)	[{"date":"2023-12-31","value":-1331200000,"profit":false}]

	Dec '23
Operating Activities
Net Operating Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Investing Activities
Net Investing Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Net Change in Cash	-	[{"date":"2023-12-31","value":"-","profit":true}]

Free Cash Flow
Free Cash Flow	-	[{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	MTSR
Current Ratio	2.66

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	MTSR
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	MTSR
Debt Ratio Lower is generally better. Negative is bad.	1.68
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-0.68

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	MTSR
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
Price/FCF	NM
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Metsera Inc. share price today?

Metsera Inc. (MTSR) share price today is $30.58

Can Indians buy Metsera Inc. shares?

Yes, Indians can buy shares of Metsera Inc. (MTSR) on Vested. To buy Metsera Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MTSR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Metsera Inc. be purchased?

Yes, you can purchase fractional shares of Metsera Inc. (MTSR) via the Vested app. You can start investing in Metsera Inc. (MTSR) with a minimum investment of $1.

How to invest in Metsera Inc. shares from India?

You can invest in shares of Metsera Inc. (MTSR) via Vested in three simple steps:

Click on Sign Up or Invest in MTSR stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Metsera Inc. shares

What is Metsera Inc. 52-week high and low stock price?

The 52-week high price of Metsera Inc. (MTSR) is $32.05. The 52-week low price of Metsera Inc. (MTSR) is $18.

What is Metsera Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Metsera Inc. (MTSR) is 0.00

What is the Market Cap of Metsera Inc.?

The market capitalization of Metsera Inc. (MTSR) is $3.15B

What is Metsera Inc.’s stock symbol?

The stock symbol (or ticker) of Metsera Inc. is MTSR